An additional study even estimates that 28% of DLBCL associated with altered MYC expression harbor DDX3X mutations that are particularly enriched in tumors defined as single-hit lymphoma (MYC but no other rearrangements) and c-MYC cluster-amplified lymphoma (140, 141). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.